Transforming growth factor-β1 increases glucocorticoid binding and signaling in macrophages through a Smad- and activated protein-1-mediated process

Kidney International

Volumn 63, Issue 6, 2003, Pages 2028-2036

  Peltier, Julie ^a   Perez, Joëlle ^a   Bellocq, Agnès ^a   Escoubet, Brigitte ^a   Fouqueray, Bruno ^a   Baud, Laurent ^a  

^a HÔPITAL TENON   (France)

Author keywords

Glucocorticoid; Inflammation; Smad

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; MESSENGER RNA; OLIGONUCLEOTIDE; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSCRIPTION FACTOR AP 1; TRANSFORMING GROWTH FACTOR BETA1; TRITIUM;

ARTICLE; BINDING AFFINITY; BINDING SITE; CELL ADHESION; CELL DIFFERENTIATION; CONCENTRATION RESPONSE; DNA RESPONSIVE ELEMENT; GENETIC TRANSCRIPTION; GLUCOCORTICOID RESPONSIVE ELEMENT; HORMONE BINDING; HORMONE SENSITIVITY; INFLAMMATORY CELL; MACROPHAGE; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; RIBONUCLEASE PROTECTION ASSAY; SIGNAL TRANSDUCTION; TRANSACTIVATION; WESTERN BLOTTING;

EID: 0037513426     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.63.6s.3.x     Document Type: Article

References (35)

1. BAUD L, FOUQUERAY B, BELLOCQ A: Cytokines and hormones with anti-inflammatory effects: New tools for therapeutic intervention. Curr Opin Nephrol Hypertens 10:49-54, 2001
2. BARNES PJ: Anti-inflammatory actions of glucocorticoids: Molecular mechanisms. Clin Sci 94:557-572, 1998
3. KARIN M: New twists in gene regulation by glucocorticoid receptor: Is DNA binding dispensable? Cell 93:487-490, 1998
4. BRÖNNEGARD M: Steroid receptor number. Individual variation and downregulation by treatment. Am J Respir Crit Care Med 154:S28-S33, 1996
5. SPAHN JD, SZEFLER SJ, SURS W, et al: A novel action of IL-13. Induction of diminished monocyte glucocorticoid receptor-binding affinity. J Immunol 157:2654-2659, 1996
6. FRANCHIMONT D, MARTENS H, HAGELSTEIN M-T, et al: Tumor necrosis factor α decreases, and interleukin-10 increases, the sensitivity of human monocytes to dexamethasone: Potential regulation of the glucocorticoid receptor. J Clin Endocrinol Metab 84:2834-2839, 1999
7. BELLOCQ A, DOUBLIER S, SUBERVILLE S, et al: Somatostatin increases glucocorticoid binding and signaling in macrophages by blocking the calpain-specific cleavage of Hsp 90. J Biol Chem 274:36891-36896, 1999
8. TSUNAWAKI S, SPORN M, DING A, et al: Deactivation of macrophages by transforming growth factor-β. Nature 334:260-262, 1988
9. BOGDAN C, NATHAN C: Modulation of macrophage function by transforming growth factor β, interleukin-4, and interleukin-10. Ann N Y Acad Sci 685:713-739, 1993
10. KITAMURA M, FINE LG: The concept of glomerular self-defense. Kidney Int 55:1639-1671, 1999
11. PIEK E, HELDIN C-H, TEN DIJKE P: Specificity, diversity, and regulation in TGF-β superfamily signaling. FASEB J 13:2105-2124, 1999
12. SHI Y: Structural insights on Smad function in TGFβ signaling. Bioessays 23:223-232, 2001
13. BRIGINO E, HARAGUCHI S, KOUTSONIKOLIS A, et al: Interleukin 10 is induced by recombinant HIV-1 Nef protein involving the calcium/calmodulin-dependent phosphodiesterase signal transduction pathway. Proc Natl Acad Sci USA 94:3178-3182, 1997
14. PHILIPPE C, ROUX-LOMBARD P, FOUQUERAY B, et al: Membrane expression and shedding of tumour necrosis factor receptors during activation of human blood monocytes: Regulation by desferrioxamine. Immunology 80:300-305, 1993
15. WEI P, VEDECKIS WV: Regulation of the glucocorticoid receptor gene by the AP-1 transcription factor. Endocrine 7:303-310, 1997
16. ZHANG Y, FENG X-H, WU R-Y, et al: Receptor-associated Mad homologues synergize as effectors of the TGF-β response. Nature 383:168-172, 1996
17. STÖCKLIN E, WISSLER M, GOUILLEUX F, et al: Functional interactions between Stat5 and the glucocorticoid receptor. Nature 380:726-728, 1996
18. MORISHITA R, GIBBONS GH, HORIUCHI M, et al: Role of AP-1 complex in angiotensin II-mediated transforming growth factor-β expression and growth of smooth muscle cells: using decoy approach against AP-1 binding site. Bichem Biophys Res Commun 243:361-367, 1998
19. BELLOCQ A, SUBERVlLLE S, PHILIPPE C, et al: Low environmental pH is responsible for the induction of nitric-oxide synthase in macrophages. Evidence for involvement of nuclear factor-κB activation. J Biol Chem 273:5086-5092, 1998
20. HELDIN C-H, MIYAZONO K, TEN DIJKE P: TGF-β signalling from cell membrane to nucleus through SMAD proteins. Nature 390:465-471, 1997
21. RYUTO M, ONO M, IZUMI H, et al: Induction of vascular endothelial growth factor by tumor necrosis factor α in human glioma cells. Possible roles of SP-1. J Biol Chem 271:28220-28228, 1996
22. MENDEZ-SAMPERIO P, GARCIA E, VAZQUEZ A, et al: Regulation of interleukin-8 by interleukin-10 and transforming growth factor β in human monocytes infected with mycobacterium bovis. Clin Diagn Lab Immunol 9:802-807, 2002
23. AYANLARBATUMAN O: Ferrero AP, Diaz A, et al: Regulation of transforming growth factor-β1 gene expression by glucocorticoids in normal human T lymphocytes. J Clin Invest 88:1574-1580, 1991
24. ALMAWI WY, IRANI-HAKIME N: The antiproliferative effect of glucocorticoids: Is it related to induction of TGF-β? Nephrol Dial Transplant 13:2450-2452, 1998
25. OURSLER MJ, RIGGS BL, SPELSBERG TC: Glucocorticoid-induced activation of latent transforming growth factor-β by normal human osteoblast-like cells. Endocrinology 133:2187-2196, 1993
26. KANATANI Y, KASUKABE T, OKABE-KADO J, et al: Transforming growth factor β and dexamethasone cooperatively enhance c-jun gene expression and inhibit the growth of human monocytoid leukemia cells. Cell Growth Differ 7:187-196, 1996
27. 1 and tumor necrosis factor on induction of differentiation of human myelogenous leukemic cell lines. J Immunol 144:1311-1316, 1990
28. KAM JC, SZEFLER SJ, SURS W, et al: Combination IL-2 and IL-4 reduces glucocorticoid receptor-binding affinity and T cell response to glucocorticoids. J Immunol 151:3460-3466, 1993
29. VEDECKIS WV, ALI M, ALLEN R: Regulation of glucocorticoid receptor protein and mRNA levels. Cancer Res 49:2295s-2302s, 1989
30. YAMAMURA Y, HUA X, BERGELSON S, et al: Critical role of Smads and AP-1 complex in transforming growth factor-beta-dependent apoptosis. J Biol Chem 275:36295-36302, 2000
31. QING J, ZHANG Y, DERYNCK R: Structural and functional characterization of the transforming growth factor-β-induced Smad3/c-Jun transcriptional cooperativity. J Biol Chem 275:38802-38812, 2000
32. BRESLIN MB, VEDECKIS WV: The human glucocorticoid receptor promoter upstream sequences contain binding sites for the ubiquitous transcription factor, Ying Yang 1. J Steroid Biochem Molec Biol 67:369-381, 1998
33. TAKENAKA IM, HIGHTOWER LE: Regulation of chicken Hsp70 and Hsp90 family gene expression by transforming growth factor-β1. J Cell Physiol 155:54-62, 1993
34. SONG C-Z, TIAN X, GELEHRTER TD: Glucocorticoid receptor inhibits transforming growth factor-β signaling by directly targeting the transcriptional activation function of Smad3. Proc Natl Acad Sci USA 96:11776-11781, 1999
35. WEBSTER JC, OAKLEY RH, JEWELL CM, et al: Proinflammatory cytokines regulate human glucocorticoid receptor gene expression and lead to the accumulation of the dominant negative β isoform: A mechanism for the generation of glucocorticoid resistance. Proc Natl Acad Sci USA 98:6865-6870, 2001